Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lyftet Holding AB is a Swedish healthcare services and investment company based in Stockholm. The company primarily operates through its subsidiary, Lyftet i Sverige AB, which is a leading provider of personal assistance and home care services for individuals with functional disabilities across Sweden. Beyond its operational role in healthcare services, Lyftet Holding serves as a private investment vehicle for its owners, most notably Professor Per-Anders Abrahamsson, a prominent figure in the European urology and biotechnology sectors. The company maintains significant equity positions in several clinical-stage Nordic biotechnology firms, including Lytix Biopharma, Aptahem, and WntResearch. By combining a stable service-based business model with strategic investments in life science innovation, Lyftet Holding plays a dual role in the Swedish healthcare ecosystem. Its leadership brings deep medical expertise to its investment decisions, particularly in the fields of oncology and urology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lyftet Holding.